Hospital Acquired Infections

Catheter-Associated Urinary Tract Infection (CAUTI)

Catheter-associated urinary tract infections (CAUTIs) are the most common type of health care-associated infection and account for 35 percent of all such infections. CAUTIs have been associated with increased morbidity, mortality, costs, and length of stay. Yet, the vast majority of CAUTIs are preventable.

Goal: By September 27, 2018, a 20 percent reduction in Catheter-Associated Urinary Tract Infections

Central Line-Associated Bloodstream Infection (CLABSI)

CLABSI is a bloodstream infection that occurs within a central line - a catheter used to deliver or measure a patient's essential fluids. While the adoption and implementation of evidence-based practices has been associated with substantial reductions in CLABSIs, more work is underway to prevent patient harm in non-critical care settings, including hemodialysis centers and inpatient wards.

Goal: By September 27, 2018, a 20 percent reduction in Central Line-Associated Bloodstream Infections

Clostridium Difficile Infection (C. diff or CDI) and Antibiotic Stewardship

Clostridium difficile infection (C. diff or CDI) is healthcare-associated infection (HAI) in hospitals, other healthcare facilities and the community at large. C. diff infections commonly develop after prolonged exposure to antibiotics, which increases C. difficile bacteria growth. While all patients taking antibiotics are at risk of CDI, longer courses of antibiotic therapy and multiple courses of antimicrobials increase CDI risk. NEED TO END THIS PARAGRAPH WITH A STATEMENT ON HOW WE ARE ADDRESSING THIS (PER MC EDITS)

Goal: By September 27, 2018, a 20 percent reduction in Clostridium Difficile Infections

Multi-Drug Resistant Organisms (MDRO)

Antimicrobial resistance has become widespread over the past several decades. Multi-drug resistant organisms (MDROs) are microorganisms, predominantly bacteria, that are resistant to one or more antimicrobial agents. Common MDROs include methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus aureus with resistance to vancomycin (VISA/VRSA), vancomycin-resistant Enterococci (VRE), extended spectrum beta-lactamase-producing gram-negative bacilli (ESBLs), multidrug-resistant Streptococcus pneumoniae (MDRSP), carbapenem-resistant enterobacteriaceae (CRE), and multidrug-resistant Acinetobacter.

Preventing MDRO transmission and resulting infections requires a comprehensive approach based upon a hospital's individual infection risk assessment. The prevalence of MDRO burden varies across geographical regions, by size and type of hospital, and even within settings. An integrated systems approach that encompasses both MDRO prevention and a strong antimicrobial stewardship program (ASP) will allow hospitals to quickly identify new emerging MDRO strains, as well as to address the challenges of increased resistance patterns in the hospital and surrounding communities.

Goal: By September 27, 2018, a 20 percent reduction in Multi-Drug Resistant Organisms

Surgical Site Infection (SSI)

Between two and five percent of all patients who have undergone a surgical procedure will develop a SSI. SSIs are now the most common and expensive hospital-acquired infection in the United States. It is estimated that 60 percent of SSIs are potentially preventable. For continuity/consistency - first define what an SSI is, then indicate how we are working to address it (PER MC EDITS)

Goal: By September 27, 2018, a 20 percent reduction in Surgical Site Infections

Ventilator-Associated Event (VAE)

Over a quarter million patients in the United States receive mechanical ventilation each year, putting them at risk for acute lung injury, including mortality related to pneumonia and acute respiratory distress syndrome, and other lung injuries. Of patients on mechanical ventilation, the elderly, aged 85 years and older, are at a higher risk for lung injury. Poor outcomes after mechanical ventilation include: extended time on mechanical ventilation, longer stays in the intensive care unit and hospital, increased health care costs and increased risk of disability and death.

To establish more objective surveillance criteria, the Centers for Disease Control and Prevention (CDC) transitioned from VAP to VAE surveillance in adult inpatient settings in 2013. VAE surveillance detects a broader range of conditions and events are classified into three hierarchical tiers: ventilator-associated conditions (VAC), infection-related ventilator-associated complication and possible/probable VAP. Research to date leads us to believe that most VACs, the broadest of the three tiers, are due to pneumonia, acute respiratory distress syndrome, atelectasis and pulmonary edema and may be preventable.

Goal: By September 27, 2018, a 20 percent reduction in Ventilator-Associated Events.